Literature DB >> 15034835

Clinical features related to antiphospholipid syndrome in patients with chronic viral infections (hepatitis C virus/HIV infection): description of 82 cases.

Manuel Ramos-Casals1, Ricard Cervera, Mariana Lagrutta, Francisco Medina, Mario García-Carrasco, Gloria de la Red, Albert Bové, Miguel Ingelmo, Josep Font.   

Abstract

We analyzed the spectrum of clinical features related to antiphospholipid syndrome (APS) in patients with chronic viral infections, such as hepatitis C virus (HCV) infection and human immunodeficiency virus (HIV) infection. We selected patients from the HISPAMEC registry who repeatedly tested positive for antiphospholipid antibodies (aPL) and who had features of APS, and we searched the MEDLINE database for additional cases. A total of 82 patients were included (45 had chronic HCV infection, 32 had HIV infection, and 5 had HCV-HIV coinfection). The main features of APS were avascular bone necrosis (20 patients), peripheral thrombosis (17), thrombocytopenia (15), neurologic features (13), cardiac manifestations (12), pulmonary embolism (9), gastrointestinal manifestations (8), and cutaneous manifestations (8). The main APS-related features in HCV-infected patients were intraabdominal thrombosis and myocardial infarction, whereas, in HIV-infected patients, the main features were avascular bone and cutaneous necrosis. These viruses might act in some patients as chronic triggering agents that induce a heterogeneous, atypical presentation of APS.

Entities:  

Mesh:

Year:  2004        PMID: 15034835     DOI: 10.1086/382537

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  13 in total

1.  Antiphospholipid antibodies in HIV-positive patients.

Authors:  Liliana Galrão; Carlos Brites; Maria Luíza Atta; Ajax Atta; Isabella Lima; Fernanda Gonzalez; Fernanda Magalhães; Mittermayer Santiago
Journal:  Clin Rheumatol       Date:  2007-02-28       Impact factor: 2.980

2.  A clinical cardiology perspective of thrombophilias.

Authors:  Richard C Becker
Journal:  J Thromb Thrombolysis       Date:  2010-10       Impact factor: 2.300

3.  Portal vein thrombosis in a patient with hepatitis C virus-related cirrhosis complicated with antiphospholipid syndrome.

Authors:  Yohei Kida; Etsuko Maeshima; Yoichi Yamada
Journal:  Rheumatol Int       Date:  2009-01-28       Impact factor: 2.631

4.  Antiphospholipid syndrome and acute HIV infection.

Authors:  Jaime Solis Diaz; Juan Gomez Octavio; Manuel L Fernandez-Guerrero
Journal:  Emerg Infect Dis       Date:  2010-02       Impact factor: 6.883

Review 5.  Systematic review of case reports of antiphospholipid syndrome following infection.

Authors:  N Abdel-Wahab; M A Lopez-Olivo; G P Pinto-Patarroyo; M E Suarez-Almazor
Journal:  Lupus       Date:  2016-04-07       Impact factor: 2.911

Review 6.  Orthopedic involvement in antiphospholipid syndrome.

Authors:  Alexander Gorshtein; Yair Levy
Journal:  Clin Rev Allergy Immunol       Date:  2007-04       Impact factor: 8.667

Review 7.  Primary versus secondary antiphospholipid syndrome: is this lupus or not?

Authors:  Jennifer M Grossman
Journal:  Curr Rheumatol Rep       Date:  2004-12       Impact factor: 4.686

8.  Characterization of antiphospholipid antibodies in chronic hepatitis B infection.

Authors:  Ji Young Huh; Dae Young Yi; Seong Gyu Hwang; Jin Jung Choi; Myung Seo Kang
Journal:  Korean J Hematol       Date:  2011-03-15

Review 9.  Hepatitis C virus and autoimmunity.

Authors:  Barbara C Böckle; Norbert T Sepp
Journal:  Auto Immun Highlights       Date:  2010-07-10

Review 10.  Kaleidoscope of autoimmune diseases in HIV infection.

Authors:  Justyna Roszkiewicz; Elzbieta Smolewska
Journal:  Rheumatol Int       Date:  2016-08-20       Impact factor: 3.580

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.